Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Ocata Therapeutics, Inc. | actc_8k-091714.htm |
Exhibit 16.1
September 23, 2014
PCAOB Letter File
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549-7561
Commissioners:
We have read Advanced Cell Technology, Inc. and Subsidiary's statements included under Item 4.01 of its Form 8-K filed on September 23, 2014, and we agree with such statements concerning our firm.
/s/ SingerLewak LLP
SingerLewak LLP
Los Angeles, California
10960 Wilshire Blvd., 7th Floor Los Angeles, CA 90024 T: 310.477.3924 F: 310.478.6070
877.754.4557